UNSPSC 51182022: Clostebol

This classification denotes an anabolic steroid with the molecular formula C19H27ClO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z7D4G976SH, chemically known as testosterone, 4-chloro-, acetate but generally known as clostebol, which bears US NIH Compound Identifier 13327. European Medicines Agency schedules Clostebol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06771MIG.

UNSPSC 51182022 Clostebol is a Commodity code identifying a synthetic anabolic steroid pharmaceutical product. State and local governments procure clostebol primarily for use in public health clinics, correctional facilities, and sports medicine programs operated by state health departments and county medical services. The product is typically sourced through established pharmaceutical supply contracts or direct purchase orders from licensed distributors and pharmaceutical manufacturers. Clostebol remains a controlled substance in most jurisdictions and its procurement is subject to strict regulatory oversight, licensing requirements, and chain-of-custody documentation.

The recent state and local opportunities database shows no posted solicitations or contract awards under this Commodity code. Without documented procurement activity in the public record, the current demand signal for clostebol across state and local entities cannot be assessed. Interested firms should monitor the procurement channels of state health departments, county health services, and correctional health programs for any future opportunities, and verify regulatory and licensing requirements before pursuing work in this product category.